Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structure-/disease-modifying agents for osteoarthritis.

Roy D Altman1

  • 1Division of Rheumatology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. journals@royaltman.com

Seminars in Arthritis and Rheumatism
|October 7, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Colchicine twice a day for hand osteoarthritis (COLOR): a double-blind, randomised, placebo-controlled trial.

The Lancet. Rheumatology·2024
Same author

Comparative effectiveness of pharmacological interventions for hand osteoarthritis: a systematic review and network meta-analysis of randomised trials.

RMD open·2023
Same author

Prognostic value of illness perception on changes in knee pain among elderly individuals: Two-year results from the Frederiksberg Cohort study.

Osteoarthritis and cartilage open·2023
Same author

Osteoarthritis Research Society International (OARSI): Past, present and future.

Osteoarthritis and cartilage open·2022
Same author

Missing the Mark? American College of Rheumatology 2019 Guidelines for Intraarticular Hyaluronic Acid Injection and Osteoarthritis Knee Pain.

The Journal of rheumatology·2022
Same author

Risk of Severe Acute Localized Reactions for Different Intraarticular Hyaluronic Acid Knee Injections in a Real-World Setting.

Cartilage·2021
Same journal

Predictors of relapse, early escalation and 1-Year use of glucocorticoids in new-onset polymyalgia rheumatica: A prospective cohort study.

Seminars in arthritis and rheumatism·2026
Same journal

Postoperative complications and outcomes after surgical treatment for tophaceous gout: A systematic review and meta-analysis.

Seminars in arthritis and rheumatism·2026
Same journal

Autoantibody associations in patients with early diffuse cutaneous systemic sclerosis: the prospective registry of early systemic sclerosis.

Seminars in arthritis and rheumatism·2026
Same journal

Effectiveness and safety of primary thromboprophylaxis in antiphospholipid antibody carriers by serological 2023 ACR/EULAR domains.

Seminars in arthritis and rheumatism·2026
Same journal

Clustering-based stratification of fibromyalgia subtypes: A comparative analysis of medicated and non-medicated cohorts from two academic centers.

Seminars in arthritis and rheumatism·2026
Same journal

Imaging techniques for assessing the hand in systemic sclerosis: a systematic review.

Seminars in arthritis and rheumatism·2026
See all related articles

Osteoarthritis (OA) is a common joint disease, with aging as a key risk factor. Current therapies aim to modify disease structure, but effective interventions remain elusive.

Area of Science:

  • Rheumatology
  • Orthopedics
  • Gerontology

Background:

  • Osteoarthritis (OA) is the most prevalent articular disease, significantly impacting aging populations.
  • Inflammation plays an increasingly recognized role in OA pathogenesis.
  • OA affects the entire joint, not solely cartilage, prompting a shift towards structure/disease modification therapies.

Purpose of the Study:

  • To highlight the growing need for enhanced understanding and superior therapies for Osteoarthritis (OA).
  • To emphasize the evolving perspective of OA as a whole-joint disease with an inflammatory component.
  • To discuss the interest in structure/disease modification as a therapeutic goal for OA.

Main Methods:

  • Review of current literature on Osteoarthritis (OA) epidemiology and risk factors.

Related Experiment Videos

  • Analysis of the role of inflammation in OA pathogenesis.
  • Examination of emerging therapeutic strategies focused on structure/disease modification.

    • Main Results:

    • Aging populations necessitate improved OA understanding and treatments.
    • Inflammation is a critical factor in OA development and progression.
    • No universally effective structure/disease-modifying interventions for OA are currently established.

    Conclusions:

    • Osteoarthritis (OA) management requires a comprehensive approach considering the entire joint and inflammatory pathways.
    • Further research is crucial to develop proven structure/disease-modifying therapies for OA.
    • The aging demographic underscores the urgency for advancements in OA treatment and prevention.